Neuraxis, INC SEC filings NRXS

Neuraxis, INC has 193 filings in SEC EDGAR's recent list, going back to Sep 27, 2022. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (other events). The company's fiscal year ends on December 31.

Neuraxis, INC SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 10, 2026
DEFA14A Additional proxy material Apr 14, 2025 —
DEF 14A Proxy statement Apr 14, 2025 May 29, 2025
PRE 14A Preliminary proxy statement Apr 4, 2025 May 29, 2025
DEFA14A Additional proxy material Jul 1, 2024 —
DEF 14A Proxy statement Jul 1, 2024 Aug 15, 2024
PRE 14A Preliminary proxy statement Jun 21, 2024 Aug 15, 2024

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NRXS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carmel, IN
SEC filer status
, Emerging growth company
SEC CIK
1933567

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.